Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jooeun Kang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|October 20, 2021
Addressing Microaggressions in the Health Care Workplace: Giving Trainees a VoiceSharon Kam, Jooeun Kang
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 17, 2020
Expanding cultural and ancestral representation in psychiatric genetic studiesJooeun Kang, Douglas M Ruderfer
Psychological Medicine|May 25, 2021
Genetic contributions to suicidal thoughts and behaviorsEmily DiBlasi, Jooeun Kang, Anna R Docherty
Journal of Cardiac Surgery|July 12, 2020
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD managementCarlo R Bartoli, Jooeun Kang, Tadashi Motomura
The Annals of Thoracic Surgery|October 9, 2016
Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist SystemCarlo R Bartoli, Jooeun Kang, David Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2022
Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleedingSamson Hennessy-Strahs, Jooeun Kang, Eric Krause, et al.
JACC. Heart Failure|October 12, 2015
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated BleedingCarlo R Bartoli, Jooeun Kang, David J Restle, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 15, 2016
Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradationJooeun Kang, David M Zhang, David J Restle, et al.
Circulation. Heart Failure|October 26, 2018
Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters AngiogenesisCarlo R Bartoli, David M Zhang, Samson Hennessy-Strahs, et al.
Circulation Research|July 22, 2017
Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal AngiodysplasiaJooeun Kang, Samson Hennessy-Strahs, Pawel Kwiatkowski, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Academic Medicine : Journal of the Association of American Medical Colleges|October 20, 2021
Addressing Microaggressions in the Health Care Workplace: Giving Trainees a VoiceSharon Kam, Jooeun Kang
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 17, 2020
Expanding cultural and ancestral representation in psychiatric genetic studiesJooeun Kang, Douglas M Ruderfer
Psychological Medicine|May 25, 2021
Genetic contributions to suicidal thoughts and behaviorsEmily DiBlasi, Jooeun Kang, Anna R Docherty
Journal of Cardiac Surgery|July 12, 2020
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD managementCarlo R Bartoli, Jooeun Kang, Tadashi Motomura
The Annals of Thoracic Surgery|October 9, 2016
Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist SystemCarlo R Bartoli, Jooeun Kang, David Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2022
Patient-specific severity of von Willebrand factor degradation identifies patients with a left ventricular assist device at high risk for bleedingSamson Hennessy-Strahs, Jooeun Kang, Eric Krause, et al.
JACC. Heart Failure|October 12, 2015
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated BleedingCarlo R Bartoli, Jooeun Kang, David J Restle, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 15, 2016
Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradationJooeun Kang, David M Zhang, David J Restle, et al.
Circulation. Heart Failure|October 26, 2018
Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters AngiogenesisCarlo R Bartoli, David M Zhang, Samson Hennessy-Strahs, et al.
Circulation Research|July 22, 2017
Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal AngiodysplasiaJooeun Kang, Samson Hennessy-Strahs, Pawel Kwiatkowski, et al.
Pageof 3